The Footnote

If It Walks Like a Duck… It’s a Medical Device

Author attribution not recorded

A store display where a single, ordinary insole is being examined under a magnifying glass, exposing its lack of clinical status.

Orthotics are like medicines—dose them right and lives improve, dose them wrong and you’re just flogging expensive sugar pills.

 

The Saturday-Morning Shoe-Store Confessional

It begins innocently enough: a runner wanders into a sports chain for “new kicks.” A pressure mat flashes red at the big toe, the sales rep frowns gravely, declares “excessive pronation,” and produces an $80 insole guaranteed to fix the problem. Our runner leaves poorer, still injured, and blissfully unaware they’ve just received a medical intervention from someone whose last biomechanics lecture was a YouTube ad.

That switch—from comfort advice to clinical promise—is the precise moment an insert becomes a medical device under Australian law.¹ The rep has stepped (perhaps unknowingly) into regulated-health-care territory.

 

From Cushion to Cure: When an Insert Crosses the Line

Australian legislation doesn’t care what something looks like; it cares what it’s intended to do. The Therapeutic Goods Act defines a medical device as any article “intended… for diagnosis, prevention, monitoring, treatment or alleviation of disease or injury.”¹

Two key points hide in that sentence:

  • Intended use—Marketing claims, not materials, trigger regulation.

  • Treatment focus—Pain, pathology or biomechanical dysfunction all count.

So:

  • Gel cushions advertised purely for comfort? Fair game.

  • Off-the-shelf insoles promoted to “cure plantar fasciitis”? Class I medical devices, requiring registration on the Australian Register of Therapeutic Goods (ARTG) and compliance with the TGA’s Essential Principles.²

Since February 2021, custom foot orthoses have also been captured as patient-matched devices. Manufacturers who lodged a transition notification by 1 November 2024 may keep supplying under exemption, but all must be fully included on the ARTG by 1 July 2029.³ ⁴

 

Who Gets to Prescribe?

  • Podiatrists—Explicitly trained and endorsed to assess, prescribe and supply custom foot orthoses.⁵ ⁶

  • Physiotherapists (Advanced Practice)—May prescribe within a defined musculoskeletal scope after meeting national competency standards and local credentialing.⁷ ⁸

  • Chiropractors—May supply prefabricated or custom orthoses within their musculoskeletal scope of practice so long as claims remain evidence-based and compliant with advertising rules; they must not imply exclusive expertise in podiatric diagnosis or cure.⁹

  • Retail staff, franchisees, “footwear specialists”—Welcome to sell comfort. Not authorised to prescribe pathology-treating devices.

Yet social media brims with #FootScan videos proclaiming “severe pronation” in 30 seconds. The line between retail and healthcare is increasingly faint.

 

Risks of Shortcut Footcare

  • Misdiagnosis – Pressure mats produce data that require clinical context. Untrained interpretation can mistake normal variation for pathology, delaying real treatment.¹⁰

  • Disease progression – Ill-fitting “orthotics” can worsen diabetic ulcer risk, promote maladaptive gait or accelerate joint degeneration.¹¹

  • Lost time and money – A $400 prefab insert is cheaper than surgery—until it fails. Patients circle back months later, in worse condition and out of pocket.

  • Liability blind spots – If a non-registered seller’s device aggravates an injury, the indemnity trail is murky.

 

Around the World—Same Duck, Different Pond

  • United States – The FDA classes orthotic devices as medical when intended for treatment, usually Class I or II.¹²

  • Canada – Provincial colleges regulate dispensing; recent fraud probes into chiropractic clinics underscore credential importance.¹³

  • European Union – Regulation (EU) 2017/745 broadened oversight of custom-made devices, mirroring Australia’s patient-matched model.¹⁴

Global trend: tighter regulation and clearer professional boundaries.

 

3-D Printing, Smart Orthoses and the Next Grey Zone

Additive manufacturing lets clinics—and hobbyists—print “custom” insoles overnight. AI-driven gait apps promise a personalised script for $9.99. Innovation is welcome, but every leap widens the regulatory grey zone. The TGA anticipates 3-D printing, yet enforcement relies on proactive compliance.²

 

Fixing the Loophole

  • Clear labelling – Any product claiming clinical benefit must show its ARTG number and the practitioner type authorised to prescribe it.

  • Consumer campaign – Teach every shopper to ask, “Is this device registered, and who prescribed it?”

  • Retail boundaries – Mandatory disclaimers: “We do not diagnose or treat medical conditions.”

  • Real penalties – Fines proportional to turnover, not token slaps on the insole.

  • Accredited pathways – Transparent postgraduate courses for physios and chiros seeking orthotic-prescribing rights.

 

Clinician Checklist

  1. Confirm ARTG status or manufacturer compliance for every device.

  2. Document full biomechanical assessment and rationale.

  3. Provide written instructions, break-in schedule and red-flag warnings.

  4. Book follow-ups to adjust or discontinue if adverse effects appear.

  5. Retain manufacturing files for seven years (TGA requirement).²

 

Consumer Litmus Test

Before buying “orthotics,” ask:

  1. Who prescribed this, and what are their qualifications?

  2. Is it on the ARTG?

  3. Will I receive a written diagnosis and plan?

  4. What follow-up care is included?

  5. What if it makes things worse?

If any answer feels slippery, waddle away.

 

Conclusion—Don’t Duck the Device

Orthotics and therapeutic footwear are powerful, evidence-based tools when wielded by trained professionals. Misused, they devolve into costly gadgets that erode trust and harm patients. Recognising that the claim—not the cushion—makes the medical device protects consumers, elevates allied health and leaves the quackery to the birds.

 

References

  1. Therapeutic Goods Administration. Understanding medical device definitions and rules for system or procedure packs [Internet]. Canberra: TGA; 2024 [cited 2025 Aug 4]. Available from: https://www.tga.gov.au/

  2. Therapeutic Goods Administration. Personalised medical devices: guidance for manufacturers and sponsors [Internet]. Canberra: TGA; 2024 [cited 2025 Aug 4].

  3. Therapeutic Goods Administration. Patient-matched medical devices: transition arrangements [Internet]. Canberra: TGA; 2025 [cited 2025 Aug 4].

  4. Australian Orthotic Prosthetic Association. Regulation of orthotic/prosthetic devices by the TGA: guide to the patient-matched transition period [PDF]. Melbourne: AOPA; 2021.

  5. Podiatry Board of Australia. Code of conduct [Internet]. Melbourne: Ahpra; 2025 [cited 2025 Aug 4].

  6. Australian Podiatry Association. Prescription orthoses [Internet]. 2025 [cited 2025 Aug 4].

  7. Australian Physiotherapy Association. National Advanced Practice Physiotherapy Competency Framework. Melbourne: APA; 2024.

  8. Australian Physiotherapy Association. Statement on advanced practice physiotherapy. Melbourne: APA; 2024.

  9. Chiropractic Board of Australia. Code of conduct [Internet]. Melbourne: Ahpra; 2025 [cited 2025 Aug 4].

  10. Tekscan Inc. Versatile pressure-sensing mats and walkways [Internet]. 2025 [cited 2025 Aug 4].

  11. Frykberg RG, Gordon IL, Reyzelman AM, et al. Feasibility and efficacy of a smart mat technology to predict development of diabetic plantar ulcers. Diabetes Care. 2017;40(7):973-80.

  12. U.S. Food and Drug Administration. Is the product a medical device? [Internet]. 2024 [cited 2025 Aug 4].

  13. Koziebrocki Law. What chiropractors need to know about prescribing and dispensing orthotics [Internet]. Toronto; 2024 [cited 2025 Aug 4]. (Canadian context)

  14. European Union. Regulation (EU) 2017/745 of 5 Apr 2017 on medical devices. Off J Eur Union. 2017;L117:1-175.

Simplified complete reading view